# Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma

> **NCT06365034** · — · UNKNOWN · sponsor: **Qianfoshan Hospital** · enrollment: 92 (estimated)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06365034
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2025-01-31
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2024-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06365034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06365034, "Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06365034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*